US$ 24.45
glp 1 drugs adverse effects Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks India Issues GLP-1 Drug Safety
Description
Drucker, D., Easley, C
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: past, present, and future
We conclude by discussing existing gaps in the literature and proposing directions for future research

Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related alzheimers disease by exendin-4
It helps maintain healthy cholesterol and blood sugar levels, as well as GI microbial balance

But it produces less weight loss than retatrutide, which targets all three receptors
